The absence of SIRT3 led to hyperacetylation of LCAD at Lys318 and Lys322 which was found to contribute to a decrease in beta-oxidation and increased lipid accumulation, promoting MetS [73,75,76]. This evidence concerns the gene SIRT3 and metabolic syndrome.